Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease
Authors:
Open Access
- 15 September 2025
- journal article
- immunology
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1656489
Abstract
We investigated the diagnostic challenges of TAFRO syndrome and idiopathic multicentric Castleman disease (iMCD), focusing on the usefulness of anterior mediastinal lesions for distinguishing the disease subtypes. A comparative analysis using computed tomography (CT) imaging was performed for three patient groups: TAFRO without iMCD/iMCD-TAFRO (n=13), iMCD-idiopathic plasmacytic lymphadenopathy (IPL)- not otherwise specified (NOS) (n=16), and IgG4-related disease (IgG4-RD) (n=59). Lesions were categorized into increased fat density, micronodular opacity, and mass. The lesions’ CT attenuation values were compared, and receiver operating characteristic (ROC) curve analyses assessed their diagnostic relevance. Anterior mediastinal lesions were most frequent in the TAFRO without iMCD/iMCD-TAFRO group (85%) compared to the iMCD-IPL/NOS group (31%) and IgG4-RD group (6.8%). Distinct patterns such as increased fat density were predominantly observed in the TAFRO without iMCD/iMCD-TAFRO group. The CT values showed significant intergroup differences, with ROC analyses confirming high diagnostic accuracy for distinguishing the TAFRO without iMCD/iMCD-TAFRO group from the other groups. Post-treatment, all patients with TAFRO without iMCD/iMCD-TAFRO showed improvement in CT readings, whereas only half of the patients with iMCD-NOS group showed changes. These findings emphasize the importance of CT-detected anterior mediastinal lesions in the diagnosis of TAFRO without iMCD/iMCD-TAFRO and warrant further research to validate these results.Keywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 20 references indexed in Scilit:
- International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning AnalysisAmerican Journal of Hematology, 2025
- Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution PatternsAmerican Journal of Hematology, 2025
- Castleman disease and TAFRO syndromeAnnals of Hematology, 2022
- Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman diseaseAmerican Journal of Hematology, 2021
- Optimal treatments for TAFRO syndrome: a retrospective surveillance study in JapanInternational Journal of Hematology, 2020
- Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalitiesEuropean Radiology, 2020
- 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndromeInternational Journal of Hematology, 2019
- CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's diseaseClinical Radiology, 2017
- An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapyRespirology Case Reports, 2016
- Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV‐8‐negative multicentric Castleman diseaseAmerican Journal of Hematology, 2015